Caroline Stout is a Partner at EcoR1 Capital. Ms. Stout joined EcoR1 in 2014 and has led several of the firm’s investments in the biotechnology sector. She has also served as Chief Investment Officer of Panacea Acquisition Corp I and II. Prior to joining EcoR1, Ms. Stout worked as an investment banker at Credit Suisse in New York. She currently serves as a Board Member of four private biotechnology companies: Accent Therapeutics, Affinia Therapeutics, Notch Therapeutics, and Tectonic Therapeutic. Ms. Stout graduated magna cum laude from Georgetown University with a Bachelor of Arts in Economics, a Pre-Medical concentration, and Cognitive Science minor.